Sunil Healthcare

₹85 0 | 0%

WEBSITE BSE:537253 NSE : SUNIL HEALTH 18 May, 12:50

Market Cap ₹87 Cr.

Stock P/E -58.5

P/B 1.7

Current Price ₹85

Book Value ₹ 49.7

Face Value 10

52W High ₹100.9

Dividend Yield 0%

52W Low ₹ 45.7

Edit Ratio

Sunil Healthcare Research see more...

Overview Inc. Year: 1973Industry: Chemicals

Sunil Healthcare Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Sunil Healthcare Quarterly Results

#(Fig in Cr.)	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Net Sales	29	31	32	33	31	25	21	23	24	23
Other Income	0	0	1	1	2	1	1	1	0	3
Total Income	30	32	33	34	32	26	22	24	24	26
Total Expenditure	27	26	25	26	27	23	19	22	22	23
Operating Profit	3	5	8	8	6	3	4	2	1	3
Interest	1	1	1	1	1	1	1	1	1	1
Depreciation	2	2	2	2	2	2	2	2	2	1
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	0	3	6	6	3	0	1	-1	-1	-0
Provision for Tax	0	1	2	2	1	0	0	-0	-0	-0
Profit After Tax	0	2	4	4	2	-0	0	-1	-1	-0
Adjustments	0	0	0	0	0	0	0	0	-0	0
Profit After Adjustments	0	2	4	4	2	-0	0	-1	-1	-0
Adjusted Earnings Per Share	0	2.1	3.9	4.1	2.1	-0.1	0.4	-0.6	-1.1	-0.2

Sunil Healthcare Profit & Loss

#(Fig in Cr.)	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	102	90	81	70	91	119	110	91
Other Income	1	2	1	15	6	2	5	5
Total Income	103	93	82	85	96	121	115	96
Total Expenditure	87	76	70	78	85	102	95	86
Operating Profit	16	16	12	6	11	19	21	10
Interest	4	5	7	7	5	3	4	4
Depreciation	4	5	6	6	6	6	7	7
Exceptional Income / Expenses	0	0	0	0	0	0	0	0
Profit Before Tax	8	6	-1	-7	-1	9	9	-1
Provision for Tax	3	2	-0	-2	0	3	3	0
Profit After Tax	5	4	-1	-5	-1	6	7	-2
Adjustments	0	0	0	0	0	0	0	0
Profit After Adjustments	5	4	-1	-5	-1	6	7	-2
Adjusted Earnings Per Share	4.9	4.4	-0.7	-4.8	-0.6	6.3	6.5	-1.5

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	-8%	16%	4%	0%
Operating Profit CAGR	11%	52%	6%	0%
PAT CAGR	17%	0%	12%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	28%	37%	23%	16%
ROE Average	13%	9%	3%	5%
ROCE Average	16%	12%	8%	10%

Sunil Healthcare Balance Sheet

#(Fig in Cr.)	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	43	47	47	45	44	50	56
Minority's Interest	0	0	0	0	0	0	0
Borrowings	13	18	10	12	15	11	9
Other Non-Current Liabilities	7	8	7	7	8	9	10
Total Current Liabilities	60	68	74	66	54	40	45
Total Liabilities	123	142	138	130	121	110	121
Fixed Assets	60	71	69	70	70	70	70
Other Non-Current Assets	2	2	3	1	2	5	2
Total Current Assets	61	69	65	59	49	35	48
Total Assets	123	142	138	130	121	110	121

Sunil Healthcare Cash Flow

#(Fig in Cr.)	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	1	1	1	1	1	1	0
Cash Flow from Operating Activities	11	5	15	4	17	23	7
Cash Flow from Investing Activities	-13	-17	-3	-3	-11	-4	-3
Cash Flow from Financing Activities	2	11	-12	-2	-6	-19	-4
Net Cash Inflow / Outflow	0	-1	0	0	-1	-0	0
Closing Cash & Cash Equivalent	1	1	1	1	1	0	1

Sunil Healthcare Ratios

#	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	4.91	4.38	-0.67	-4.84	-0.62	6.26	6.52
CEPS(Rs)	9.13	9.05	4.92	1.14	5.34	12.41	13.35
DPS(Rs)	0	0	0	0	0	0	0
Book NAV/Share(Rs)	41.84	46.25	45.61	40.62	39.76	45.84	51.73
Core EBITDA Margin(%)	13.86	15.6	13.24	-11.7	5.84	14.24	14.44
EBIT Margin(%)	11.13	12.8	7.19	0.51	5.25	10.7	12.35
Pre Tax Margin(%)	7.27	6.91	-1.08	-9.42	-0.61	7.77	8.58
PAT Margin (%)	4.64	4.92	-0.85	-7.09	-0.7	5.39	6.05
Cash Profit Margin (%)	8.63	10.16	6.22	1.66	6.04	10.68	12.39
ROA(%)	4.1	3.39	-0.49	-3.7	-0.51	5.58	5.8
ROE(%)	11.72	9.95	-1.47	-11.23	-1.55	14.63	13.36
ROCE(%)	13.8	11.96	5.56	0.37	5.26	14.9	16.11
Receivable days	129.57	173.14	196.41	163.67	94.63	64.82	78.13
Inventory Days	36.28	41.78	60.08	108.06	77.71	37.96	40.73
Payable days	140.94	190.72	257.73	295.13	151.07	80.74	90.39
PER(x)	19.32	15.54	0	0	0	11.37	8.75
Price/Book(x)	2.26	1.47	0.75	0.37	0.57	1.55	1.1
Dividend Yield(%)	0	0	0	0	0	0	0
EV/Net Sales(x)	1.36	1.39	1.08	0.85	0.71	0.87	0.81
EV/Core EBITDA(x)	8.4	7.63	7.56	9.18	5.91	5.44	4.34
Net Sales Growth(%)	0	-11.13	-10.11	-13.76	29.42	31.5	-7.28
EBIT Growth(%)	0	-3.15	-50.05	-93.92	1238.39	168.2	7.04
PAT Growth(%)	0	-10.66	-115.39	-617.7	87.15	1106.52	4.07
EPS Growth(%)	0	-10.66	-115.39	-617.72	87.15	1106.45	4.07
Debt/Equity(x)	1.04	1.28	1.18	1.18	1.21	0.73	0.66
Current Ratio(x)	1.01	1.01	0.88	0.89	0.91	0.87	1.06
Quick Ratio(x)	0.83	0.86	0.66	0.52	0.65	0.6	0.76
Interest Cover(x)	2.89	2.17	0.87	0.05	0.9	3.66	3.28
Total Debt/Mcap(x)	0.46	0.87	1.57	3.24	2.1	0.47	0.6

Sunil Healthcare Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	73.53	73.53	73.53	73.53	73.53	73.53	73.53	73.53	73.53	73.53
FII	0	0	0	0	0	0	0	0	0	0
DII	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Public	26.37	26.37	26.37	26.37	26.37	26.37	26.37	26.37	26.37	26.37
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	0.75	0.75	0.75	0.75	0.75	0.75	0.75	0.75	0.75	0.75
FII	0	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	0.27	0.27	0.27	0.27	0.27	0.27	0.27	0.27	0.27	0.27
Others	0	0	0	0	0	0	0	0	0	0
Total	1.03	1.03	1.03	1.03	1.03	1.03	1.03	1.03	1.03	1.03

Pros

Company has reduced debt.

Cons

Company has a low return on equity of 9% over the last 3 years.
Debtor days have increased from 80.74 to 90.39days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.